Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 09, 2011 16:05 ET | Source: Myriad Genetics, Inc.

OnDose(R) Study Demonstrates Need for Improved Dosing Approach for Colorectal Cancer Patients

SALT LAKE CITY, June 9, 2011 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (Nasdaq:MYGN) announced today that a study published in Clinical Colorectal Cancer entitled "Body Surface Area-based Dosing of...
June 06, 2011 08:05 ET | Source: Myriad Genetics, Inc.

Myriad's PROLARIS(R) Test Shown to Significantly Predict Prostate Cancer Outcome From Needle Biopsy Tissue

SALT LAKE CITY, June 6, 2011 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (Nasdaq:MYGN) announced today that a presentation entitled "Prognostic value of a 46-gene cell cycle progression (CCP) RNA...
June 01, 2011 08:05 ET | Source: Myriad Genetics, Inc.

Myriad Genetics Completes Acquisition of Rules-Based Medicine

SALT LAKE CITY and AUSTIN, Texas, June 1, 2011 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (Nasdaq:MYGN) today announced that it has completed the previously announced acquisition of Rules-Based...
May 24, 2011 16:15 ET | Source: Myriad Genetics, Inc.

Myriad Genetics to Present at the Jefferies Global Healthcare Conference

SALT LAKE CITY, May 24, 2011 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (Nasdaq:MYGN) announced today that Mark Capone, President, Myriad Genetic Laboratories, Inc., is scheduled to present at the...
May 18, 2011 08:05 ET | Source: Myriad Genetics, Inc.

Myriad Genetics Announces Presentation of Prostate Cancer Study at American Society for Clinical Oncology Annual Meeting

SALT LAKE CITY, May 18, 2011 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (Nasdaq:MYGN) announced today the presentation of a study at the American Society of Clinical Oncology® (ASCO) Annual...
May 10, 2011 08:05 ET | Source: Myriad Genetics, Inc.

Myriad Genetics Licenses Novel Technology From Chronix Biomedical

SALT LAKE CITY, May 10, 2011 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (Nasdaq:MYGN) today announced that it has signed an agreement to license proprietary technology for the early detection of cancer...
May 03, 2011 16:05 ET | Source: Myriad Genetics, Inc.

Myriad Genetics Reports Fiscal 2011 Third Quarter Results

SALT LAKE CITY, May 3, 2011 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (Nasdaq:MYGN) today announced results for its third fiscal quarter and nine months ending March 31, 2011. Revenue for the...
April 27, 2011 16:22 ET | Source: Myriad Genetics, Inc.

Myriad Genetics Announces Agreement to Acquire Rules-Based Medicine

SALT LAKE CITY and AUSTIN, Texas, April 27, 2011 (GLOBE NEWSWIRE) -- Myriad Genetics Inc. (Nasdaq:MYGN) today announced that it has entered into a definitive merger agreement to acquire privately-held...
April 06, 2011 16:05 ET | Source: Myriad Genetics, Inc.

Myriad Genetics and BioMarin Pharmaceutical Inc. Enter Into Agreement

SALT LAKE CITY, April 6, 2011 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (Nasdaq:MYGN) today announced that it has signed an agreement with BioMarin Pharmaceutical Inc., a leading biopharmaceutical...
April 05, 2011 07:30 ET | Source: Myriad Genetics, Inc.

Myriad Genetics to Announce Fiscal Third Quarter Financial Results on Tuesday, May 3, 2011

SALT LAKE CITY, April 5, 2011 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (Nasdaq:MYGN) today announced that it will issue financial results for the third fiscal quarter following the close of market on...